Hypertensive patients' preferences for complementary and alternative medicine and the influence of these preferences on the adherence to prescribed medication

Complementary Therapies in Clinical Practice

Volumn 20, Issue 2, 2014, Pages 99-105

  Lee, Khuan ^a   Mokhtar, Halimatun Halaliah ^a   Krauss, Steven Eric ^a   Ong, Beng Kok ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Adherence; Complementary and alternative medicine; Hypertension; Qualitative research

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ALTERNATIVE MEDICINE; ATTITUDE TO HEALTH; FEMALE; HUMAN; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIHYPERTENSIVE AGENTS; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 84899473999     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2014.03.001     Document Type: Article

References (62)

1. World Health Organisation Adherence to long term therapies: evidence for action 2003, 1-43.
2. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
3. Yi-Bing W., De-Gui K., Long-Le M., Le-Xin W. Patient related factors for optimal blood pressure control in patients with hypertension. Afr Health Sci 2013, 13(3):579-583. 10.4314/ahs.v13i3.8.
4. Shin S., Song H., Oh S.K., Choi K.E., Kim H., Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2013, 36(11):1000-1005. 10.1038/hr.2013.85.
5. Ministry of Health Malaysia The third national health and morbidity survey 2006 III 2006, 1-28.
6. Turki A.K., Sulaiman S.A.S. Elevated blood pressure among patients with hypertension in General Hospital of Penang, Malaysia: does poor adherence matter?. Int J Pharm Pharm Sci 2010, 2(1):24-32.
7. Bajramovic J., Emmerton L., Tett S.E. Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect 2004, 7:221-234.
8. Gascon J.J., Sanchez-Ortuno M., Lior B., Skidmore D., Saturno P.J. Why hypertensive patients do not comply with the treatment. Fam Pract 2004, 21:125-130.
9. Dowell J., Hudson H.A. Aqualitative study of medication-taking behaviour in primary care. Fam Pract 1997, 14:269-275.
10. Benson J., Britten N. What effects do patient feel from their antihypertensive tablets and how do they react to them? Qualitative analysis of interviews with patients. Fam Pract 2005, 23:80-87. 10.1093/fampra/cmi081.
11. Britten N. Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 1994, 44:465-468.
12. Donovan J.L., Blake D.R. Patient non-compliance: deviance or reason decision-making?. Soc Sci Med 1992, 34(5):507-513.
13. Svensson S., Kjellgren K.I., Ahler J., Saljo R. Reason for adherence with antihypertensive medication. Int J Cardiol 2000, 76:157-163.
14. Wroth T.H., Pathman D.E. Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. JAm Board Fam Med 2006, 19:478-486.
15. Lihara N., Tsukamoto T., Morita S., Miyoshi C., Takabatake K., Kurosaki Y. Belief of chronically ill Japanese patients that led to intentional non-adherence to medication. JClin Pharm Ther 2005, 29:417-424.
16. Kerse N., Buetow S., Mainous A.G., Young G., Coster G., Aroll B. Physician, nurses, parents and friends: help or hindrance in compliance with diabetes self-care. JAdv Nurs 2004, 2:455-461.
17. Johnson M.J., William M., Marshall E.S. Adherent and non adherent medicine-taking in elderly hypertensive patients. Clin Nurs Res 1999, 8(4):318-335.
18. Turki A.K., Sulaiman S.A.S. Adherence to antihypertensive therapy in General Hospital of Penang: does daily dose frequency matter?. Jordan J Pharm Sc 2009, 2(20):167-176.
19. Pound P., Britten N., Morgan M., Yardley L., Pope C., Daker-White G., et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005, 61:133-155.
20. Morris L.S., Schulz R.M. Patient compliance-an overview. JClin Pharm Ther 1992, 17:283-295.
21. Morgan M. Perception and use of anti-hypertensive drugs among cultural groups. Modern medicine: Lay perspectives and experience 1996, 48-73. CL Press, London. S.J. William, M. Calnan (Eds.).
22. Roger A., Day J.C., William B., Randall F., Wood P., Healy D., et al. The meaning and management of neuroleptic medicine: a study of patient with a diagnosis of schizophrenia. Soc Sci Med 1998, 47(9):1313-1323.
23. Horne R., Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. JPsychosom Res 1999, 47:555-567.
24. Robertson M.H.B. The meaning of compliance: patient perspective. Qual Health Res 1992, 2(1):7-26.
25. Sulaeiman A., Sulaiman S., Albarq A. Hospital admission and poor adherence to antihypertensive therapy: is there any relationship?. Int J Pharm Sci 2010, 2(1):38-46.
26. Hassan N.B., Hasnah C.I., Fong K., Naing L., Awang R., Ismail S.B., et al. Identification of psychosocial factors of noncompliance in hypertension patients. JHum Hypertens 2006, 20(1):23-29.
27. Khoo K.L., Liew Y.M., Tan H., Sambhi J.S., Hatijah B.A. Patient's knowledge and attitudes towards treatment and control of hypertension: a nation-wide telephone survey conducted in Malaysia. Med J Malays 1999, 54(1):37-46.
28. Lim T.O., Ngah B.A. The Mentakab hypertension study project part II - why do hypertensives drop out of treatment?. Singapore Med J 1991, 32(4):249-251.
29. Lim T.O., Ngah B.A., Rahman R.A., Suppiah A., Chako P., Na H.H. The Mentakab hypertension study project part V - drug compliance in hypertensive patients. Singapore Med J 1992, 33(1):63-66.
30. Blaikie N. Social enquiry 2007, Polity, Cambridge.
31. Berger P.L., Luckman T. The social construction of reality 1966, Penguin Book, Victoria.
32. Schutz A. The phenomenology of the social world 1972, Heinemann, London.
33. Hsieh H.F., Shannon S.E. Three approaches to qualitative content analysis. Qual Health Res 2005, 15(9):1277-1288. 10.1177/1049732305276687.
34. Miles M.B., Huberman A.M. Qualitative data analysis 1994, Sage, Thousand Oaks. 2nd ed.
35. Lincoln Y.S., Guba E.G. Naturalistic inquiry 1985, Sage, London.
36. NCCAM (National Center for Complementary and Alternative Medicine). Available at: 2008. http://nccam.nih.gov/health/whatiscam/.
37. Farooqui M., Hassali M.A.H., Abdul Satar A.K., Shafie A.A., Farooqui M.A., Saleem F., et al. Complementary and alternative medicine (CAM) disclosure to the health care providers: a qualitative insight from Malaysian cancer patients. Complement Ther Clin Pract 2012, 18:252-256.
38. Farooqui M., Hassali M.A.H., Abdul Satar A.K., Shafie A.A., Tan B.S., Farooqui M.A. Complementary and alternative (CAM) use by Malaysia oncology patients. Complement Ther Clin Pract 2012, 18:114-120.
39. Aziz Z., Tey N.P. Herbal medicine: prevalence and predictors of use among Malaysia adults. Complement Ther Med 2009, 17:44-50.
40. Wazaify M., Alawwa I., Yasein N., Al-Saleh A., Afifi F.U. Complementary and alternative (CAM) use among Jordinian patients with chronic diseases. Complement Ther Clin Pract 2013, 19:153-157.
41. Siti Z.M., Tahir A., Fara I., Fazlin S.M.A., Sondi S., Azman A.H., et al. Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med 2009, 17:292-299.
42. Giveon S.M., Liberman N., Klang S., Kahan E. Are people who use 'natural drugs' aware of their potentially harmful side effects and reporting to family physician. Patient Educ Couns 2004, 53:5-11.
43. Gori M., Campell R.K. Natural product and diabetes treatment. Diabetes Ther 1998, 24:201-208.
44. Muhammad M., Merriam S., Suhami N. Why breast cancer patients seek traditional healers. Int J Breast Cancer 2012, 1-9. 10.1155/2012/689168.
45. Kraft K. Complementary/alternative medicine in the context of prevention of disease and maintenance of health. Prev Med 2009, 49:88-92. 10.1016/j.ypmed.2009.05.003.
46. Field T. Tai Chi research review. Complement Ther Clin Pract 2012, 17:141-146.
47. Lu W.-A., Kuo C.-D. Effects of 3-month Tai Chi Chuan on heart rate variability, blood lipid and cytokine profiles in middle-aged and elderly individuals. Complement Ther Clin Pract 2012, 6:267-272.
48. Wong L.Y., Toh M.P.H., Kong K.H. Barriers to patient referral for complementary and alternative medicine and its implications on interventions. Complement Ther Med 2010, 18:135-142.
49. Al-Faris E.A., Al Rowais N., Mohamed A.G., Al Rukban M.O., Balla Al-Noor M.A. Prevalence and pattern of alternative medicine use: the results of a household survey. Ann Saudi Med 2008, 28(1):4-10.
50. Conboy L., Kaptchuk T.J., Eisenberg D.M., Gottlied B., Acevedo-Garcia D. The relationship between social factors and attitudes towards conventional and CAM practitioners. Complement Ther Clin Pract 2007, 13(3):146-157.
51. Shmueli A., Shuval J. Satisfaction with family physician and specialists and the use of complementary and alternative medicine in Israel. Evid Based Complement Altern Med 2006, 3(2):273-278.
52. Lim M.K., Sadarangani P., Chan H.L., Heng J.Y. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med 2005, 13(1):16-24.
53. Wilkinson J.M., Jelinek H. Complementary medicine use among attendees at a rural health screening clinic. Complement Ther Clin Pract 2009, 15:80-84.
54. Zhang J., Wider B., Shang H., Li Z., Ernst E. Quality of herbal medicine: challenges and solution. Complement Ther Med 2012, 20:100-106.
55. Saw J.T., Bahari M.B., Ang H.H., Lim Y.H. Potential drug-herb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 2006, 12:236-241.
56. Tai P.L., Kai S.S. Dilemma of integration with Western medicine-views of traditional Chinese medicine practitioners in a predominant Western medical setting. Complement Ther Med 2013, 21:300-305.
57. Zollman C., Vicker A. ABC of complementary medicine: complementary medicine in conventional practice. BMJ 1999, 319(7214):901-904.
58. Benson J., Britten N. Patients' decision about whether or not to take antihypertensive drugs: qualitative study. BMJ 2002, 325:1-5.
59. Mechanic D. Sociological dimension of illness behaviour. Soc Sci Med 1995, 41:1207-1216.
60. Lisper L., Isacson D., Sjoden P., Bingefors K. Medicated hypertension patients' view and experience of information and communication concerning antihypertensive drugs. Patient Educ Couns 1997, 32:147-155.
61. Haugbolle L.S., Sorensen E.W., Henriksen H.H. Medicine and illness-related factual knowledge, perceptions and behaviour in angina pectoris patients. Patient Educ Couns 2002, 47:281-289.
62. Heath I. Awolf in sheep's clothing: a critical look at the ethics of drug taking. BMJ 2003, 327:856-858.